Advertisement
Canada markets open in 1 hour 11 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7310
    +0.0013 (+0.17%)
     
  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     
  • Bitcoin CAD

    87,533.82
    -3,668.10 (-4.02%)
     
  • CMC Crypto 200

    1,355.76
    -26.81 (-1.94%)
     
  • GOLD FUTURES

    2,341.00
    +2.60 (+0.11%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,484.25
    -180.25 (-1.02%)
     
  • VOLATILITY

    16.30
    +0.33 (+2.07%)
     
  • FTSE

    8,098.20
    +57.82 (+0.72%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Will Clinical Trial Firm Icon Pass This Market Test?

Despite last week's sell-off on the Nasdaq and S&P 500, Ireland-based contract research organization (CRO) Icon has found support and shown resilience. Icon provides phase I - phase IV clinical trial services to pharmaceutical, biotech and medical device companies.